Cargando…

From predictions to prescriptions: A data-driven response to COVID-19

The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We des...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertsimas, Dimitris, Boussioux, Leonard, Cory-Wright, Ryan, Delarue, Arthur, Digalakis, Vassilis, Jacquillat, Alexandre, Kitane, Driss Lahlou, Lukin, Galit, Li, Michael, Mingardi, Luca, Nohadani, Omid, Orfanoudaki, Agni, Papalexopoulos, Theodore, Paskov, Ivan, Pauphilet, Jean, Lami, Omar Skali, Stellato, Bartolomeo, Bouardi, Hamza Tazi, Carballo, Kimberly Villalobos, Wiberg, Holly, Zeng, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883965/
https://www.ncbi.nlm.nih.gov/pubmed/33590417
http://dx.doi.org/10.1007/s10729-020-09542-0
Descripción
Sumario:The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10729-020-09542-0) contains supplementary material, which is available to authorized users. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1007/s10729-020-09542-0)